Russell D. Hull

Calgary, AB, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 80 publications

Trade-offs constrain the success of glyphosate-free farming.

Trade-offs constrain the success of glyphosate-free farming.

Journal: Scientific reports

Published: November 27, 2023

External validation of the ADA score for predicting thrombosis among acutely ill hospitalized medical patients from the APEX Trial.

External validation of the ADA score for predicting thrombosis among acutely ill hospitalized medical patients from the APEX Trial.

Journal: Journal of thrombosis and thrombolysis

Published: December 14, 2022

An in vitro biofilm model system to facilitate study of microbial communities of the human oral cavity.

An in vitro biofilm model system to facilitate study of microbial communities of the human oral cavity.

Journal: Letters in applied microbiology

Published: July 27, 2021

Inverse relationship between body mass index and risk of venous thromboembolism among medically ill hospitalized patients: Observations from the APEX trial.

Inverse relationship between body mass index and risk of venous thromboembolism among medically ill hospitalized patients: Observations from the APEX trial.

Journal: Thrombosis research

Published: June 16, 2021

Estimation of Acutely Ill Medical Patients at Venous Thromboembolism Risk Eligible for Extended Thromboprophylaxis Using APEX Criteria in US Hospitals.

Estimation of Acutely Ill Medical Patients at Venous Thromboembolism Risk Eligible for Extended Thromboprophylaxis Using APEX Criteria in US Hospitals.

Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Published: October 08, 2019

Extended prophylaxis of venous thromboembolism with betrixaban in acutely ill medical patients with and without cancer: insights from the APEX trial.

Extended prophylaxis of venous thromboembolism with betrixaban in acutely ill medical patients with and without cancer: insights from the APEX trial.

Journal: Journal of thrombosis and thrombolysis

Published: September 08, 2019

Machine learning to predict venous thrombosis in acutely ill medical patients.

Machine learning to predict venous thrombosis in acutely ill medical patients.

Journal: Research and practice in thrombosis and haemostasis

Published: August 29, 2019

Net-clinical benefit of extended prophylaxis of venous thromboembolism with betrixaban in medically ill patients aged 80 or more.

Net-clinical benefit of extended prophylaxis of venous thromboembolism with betrixaban in medically ill patients aged 80 or more.

Journal: Journal of thrombosis and haemostasis : JTH

Published: May 02, 2019

Evaluation of unmet clinical needs in prophylaxis and treatment of venous thromboembolism in at-risk patient groups: pregnancy, elderly and obese patients.

Evaluation of unmet clinical needs in prophylaxis and treatment of venous thromboembolism in at-risk patient groups: pregnancy, elderly and obese patients.

Journal: Thrombosis journal

Published: March 15, 2019

Reduction of Cardiovascular Mortality and Ischemic Events in Acute Medically Ill Patients.

Reduction of Cardiovascular Mortality and Ischemic Events in Acute Medically Ill Patients.

Journal: Circulation

Published: February 26, 2019

Evaluation of unmet clinical needs in prophylaxis and treatment of venous thromboembolism in high-risk patient groups: cancer and critically ill.

Evaluation of unmet clinical needs in prophylaxis and treatment of venous thromboembolism in high-risk patient groups: cancer and critically ill.

Journal: Thrombosis journal

Published: December 21, 2018

Characterization of Major and Clinically Relevant Non-Major Bleeds in the APEX Trial.

Characterization of Major and Clinically Relevant Non-Major Bleeds in the APEX Trial.

Journal: TH open : companion journal to thrombosis and haemostasis

Published: December 20, 2018

Showing 1-12 of 80

Last Updated: 09/26/2026